Recent Advances in Alzheimer’s Disease Research: From Biomarkers to Therapeutic Frontiers
2024
Recent Advances in Alzheimer’s Disease Research
Editorial
Author Information
Author(s): López-Antón Raúl
Primary Institution: Department of Psychology and Sociology, University of Zaragoza
Conclusion
Recent advancements in biomarker discovery, genetic research, and AI-driven diagnostics lay the foundation for a new era of personalized medicine in Alzheimer's disease care.
Supporting Evidence
- Alzheimer's disease is characterized by a decline in cognitive function and affects millions worldwide.
- Advances in biomarkers allow for early detection of neurodegenerative changes.
- Current treatments primarily provide symptomatic relief and do not halt disease progression.
- Chronic neuroinflammation plays a key role in accelerating neurodegenerative processes.
- Genetic and epigenetic research has revealed insights into AD susceptibility and progression.
- Modulating gene expression through non-coding RNAs represents a potential therapeutic target.
- Addressing modifiable risk factors can prevent up to 40% of dementia cases.
- AI models can enhance diagnostic precision and enable patient stratification.
Takeaway
Alzheimer's disease is a serious problem that affects many people, but new research is helping us find better ways to diagnose and treat it.
Limitations
Logistical barriers often hinder the implementation of interventions, especially in resource-limited settings.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website